BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15675522)

  • 1. Safety, efficacy and cross-protectivity of a live intranasal aerosol haemorrhagic septicaemia vaccine.
    Myint A; Jones TO; Nyunt HH
    Vet Rec; 2005 Jan; 156(2):41-5. PubMed ID: 15675522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of an oil-adjuvant vaccine against haemorrhagic septicaemia in buffalo calves: cross-protection between the serotypes B:2,5 and E:2,5.
    Shah NH; Jacobs AA; Shah NH; de Graaf FK
    Vet Rec; 2001 Nov; 149(19):583-7. PubMed ID: 11730166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration.
    Hodgson JC; Finucane A; Dagleish MP; Ataei S; Parton R; Coote JG
    Infect Immun; 2005 Mar; 73(3):1475-81. PubMed ID: 15731045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunisation of cattle and buffaloes with live haemorrhagic septicaemia vaccine.
    Carter GR; Myint A; Van Khar R; Khin A
    Vet Rec; 1991 Aug; 129(9):203. PubMed ID: 1957476
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of haemorrhagic septicaemia in buffaloes and cattle with a live vaccine.
    Myint A; Carter GR
    Vet Rec; 1989 May; 124(19):508-9. PubMed ID: 2502878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intranasal vaccination of field buffaloes against haemorrhagic septicaemia with a live gdhA derivative Pasteurella multocida B:2.
    Rafidah O; Zamri-Saad M; Shahirudin S; Nasip E
    Vet Rec; 2012 Aug; 171(7):175. PubMed ID: 22815208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live haemorrhagic septicaemia vaccine for cattle and buffaloes.
    Jones TO; Myint A; Carter GR
    Vet Rec; 2002 Jan; 150(4):120. PubMed ID: 11838999
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between active protection in vaccinated buffaloes against haemorrhagic septicaemia and passive mouse protection test or serum antibody titres.
    Chandrasekaran S; Kennett L; Yeap PC; Muniandy N; Rani B; Mukkur TK
    Vet Microbiol; 1994 Aug; 41(4):303-9. PubMed ID: 7801530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of immune response and duration of protection in buffaloes immunized with haemorrhagic septicaemia vaccines.
    Chandrasekaran S; Kennett L; Yeap PC; Muniandy N; Rani B; Mukkur TK
    Vet Microbiol; 1994 Aug; 41(3):213-9. PubMed ID: 7975147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary field trails with a streptomycin-dependent vaccine against haemorrhagic septicaemia.
    De Alwis MC; Carter GR
    Vet Rec; 1980 May; 106(21):435-7. PubMed ID: 6776679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with a recombinant outer membrane protein H based Haemorrhagic septicemia vaccine in dairy calves.
    Muangthai K; Tankaew P; Varinrak T; Uthi R; Rojanasthien S; Sawada T; Sthitmatee N
    J Vet Med Sci; 2018 Jan; 80(1):68-76. PubMed ID: 29109353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of experimental haemorrhagic septicaemia with a live vaccine.
    Myint A; Carter GR; Jones TO
    Vet Rec; 1987 May; 120(21):500-1. PubMed ID: 3111071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal inoculation of recombinant DNA vaccine ABA392 against haemorrhagic septicaemia disease.
    Kang TL; Chelliah S; Velappan RD; Kabir N; Mohamad J; Nor Rashid N; Ismail S
    Lett Appl Microbiol; 2019 Nov; 69(5):366-372. PubMed ID: 31508837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ABA392/pET30a protein of Pasteurella multocida provoked mucosal immunity against HS disease in a rat model.
    Kang TL; Velappan RD; Kabir N; Mohamad J; Rashid NN; Ismail S
    Microb Pathog; 2019 Mar; 128():90-96. PubMed ID: 30584901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of haemorrhagic septicaemia alum-precipitated vaccine.
    Myint A; Jones TO
    Vet Rec; 2007 Feb; 160(5):172. PubMed ID: 17277309
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant transferrin binding protein A (rTbpA) fragments of Pasteurella multocida serogroup B:2 provide variable protection following homologous challenge in mouse model.
    Shivachandra SB; Yogisharadhya R; Kumar A; Mohanty NN; Nagaleekar VK
    Res Vet Sci; 2015 Feb; 98():1-6. PubMed ID: 25544697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a PmSLP3-based vaccine formulation that provides robust long-lasting protection against hemorrhagic septicemia-causing serogroup B and E strains of
    Fegan JE; Waeckerlin RC; Tesfaw L; Islam EA; Deresse G; Dufera D; Assefa E; Woldemedhin W; Legesse A; Akalu M; Bayissa B; Nguyen QH; Ng D; Ahn SK; Schryvers AB; Tefera TA; Moraes TF; Gray-Owen SD
    Front Immunol; 2024; 15():1392681. PubMed ID: 38835751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity provided by haemorrhagic septicaemia-subunit vaccine in ruminants.
    Maslog FS
    Dev Biol Stand; 1998; 92():301-7. PubMed ID: 9554285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific antibodies of Pasteurella multocida in newborn calves of vaccinated dams.
    el-Eragi AM; Mukhtar MM; Babiker SH
    Trop Anim Health Prod; 2001 Jul; 33(4):275-83. PubMed ID: 11474861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against haemorrhagic septicaemia induced by vaccination of buffalo calves with an improved oil adjuvant vaccine.
    Shah NH; Shah NH; de Graaf FK
    FEMS Microbiol Lett; 1997 Oct; 155(2):203-7. PubMed ID: 9351202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.